The AMAS Test For Early Detection and Monitoring of Cancer
Following is a must read for anyone contemplating Cancer testing.
This is a follow up on my earlier posts The Depths of Deceit Mammography
Even though this cheap and safe "test is a standardized, validated assay, developed over 15 years ago"...
..."Conventional cancer treatment authorities are committed to a host of expensive but highly profitable diagnostic (and treatment) techniques (mammograms, MRIs, gastrointestinal series, etc.). Were it not for the intransigence of established authorities, the AMAS test undoubtedly would be much more widely used."...
Another test that is also overlooked which was discussed in Politics in Healing : The Suppression & Manipulation of American Medicine is yet again another safe alternative to all the expensive and/or injurious/invasive tests is as follows:
"All trophoblast cells produce a unique hormone called the chorionic gonadotrophic (CGH) which is easily detected in urine. Thus if a person is either pregnant or has cancer, a simple CGH pregnancy test should confirm either or both. It does, with an accuracy of better than 92% in all cases. If the urine sample shows positive it means either normal pregnancy or abnormal malignant cancer. Griffin notes: "If the patient is a woman, she either is pregnant or has cancer. If he is a man, cancer can be the only cause." So why all of the expensive, dangerous biopsies carried to 'detect' cancerous growths? One can only assume that Medicare pays doctors a larger fee for biopsies than pregnancy tests."
The AMAS Test For Early Detection and Monitoring of Cancer by Ron Schmid, N.D.
Most people are unaware that there is a reliable, scientifically proven laboratory blood test for detecting over 99% of all cancers. "Why haven't the doctors I see ordered this test?" people often ask me. Good question. I can only answer that this is yet another example of the resistance to innovative change that the medical establishment constantly demonstrates. Most doctors are simply unaware of the AMAS test because the powers that be ignore the test, and it remains largely unknown.
AMAS stands for "anti-malignin antibody in serum." The test is extremely sensitive; blood levels of this antibody rise early in the course of the vast majority of cancers of all types, regardless of location in the body. The test is especially useful when cancer is suspected but has not been confirmed by a biopsy.
One study involving the test was published in the journal Cancer Detection and Prevention in 1994. In 125 patients and controls, 118 were subsequently diagnosed by the time the article was published. In 21 individuals who were subsequently proven to have cancer, the AMAS test was elevated. The test was normal in 94, none of whom were shown to have cancer. In three other subjects who did not have cancer, the test was elevated when first done but a second test was normal. The other seven subjects had positive AMAS tests but remained undiagnosed at the time of the article, but all showed symptoms of cancer that likely indicated its presence.
The study was consistent with other published tests that indicate that the AMAS test is over 95% reliable on the first test, and over 99% reliable when a repeat test is performed. The test is a standardized, validated assay, developed over 15 years ago by Peter Bogovich, M.D., Ph.D. Dr. Bogovich has conducted scores of studies and published widely on the test.
Another study published in the Journal of Cellular Biochemistry in 1994 stated that levels typically rise with age and are higher in individuals at high risk for cancer because of family history, but stay within normal levels even when benign growths occur. "We demonstrated that the concentration is most markedly increased within weeks of the occurrence of malignant transformation to clinical breast cancer," these researchers wrote. This study involved breast cancer, but the test is valid for all cancer types. Other researchers have written that the test is an excellent screening method.
The AMAS test also is useful in monitoring the treatment of malignancies. Levels typically return to normal within two to three months of successful treatment. Other biological markers in the blood are much less specific and are usually not elevated early in the course of disease or recurrence. Thus the AMAS test is an excellent way to screen for and detect cancer or recurrences, and to track treatment progress during treatment. Conventional cancer treatment authorities are committed to a host of expensive but highly profitable diagnostic (and treatment) techniques (mammograms, MRIs, gastrointestinal series, etc.). Were it not for the intransigence of established authorities, the AMAS test undoubtedly would be much more widely used.
posted by Chris Gupta on Saturday September 27 2003
updated on Saturday September 24 2005
URL of this article:
Drinking Water Fluoridation is Genotoxic & Teratogenic
This paper by Prof. Joe Cummins is a very important 5 minute delegation made to London Ontario Canada "Civic Works Committee" public participation meeting on January 25, 2012 on fluoride*. While a bit technical it is short and easy to grasp. A must read as it goes to the heart of the matter regarding the well established toxicity of fluoride which is well in all scientific circles even before water... [read more]
February 06, 2012 - Chris Gupta
Democracy At Work? - PPM On Fluoride
Here is a commentary on the recent (Jan, 25th, 2011) Public Participation Meeting (PPM) on Fluoride in the City of London, Ontario. The meeting started with a strong pro fluoride stance form the City engineer. His lack of knowledge on chemistry of the toxic wastes used to fluoridate water could embarrass even a high school student never mind his own profession. He blatantly violated his "duty to public welfare" as... [read more]
January 29, 2012 - Chris Gupta
"Evidence Be Damned...Patient Outcome Is Irrelevant" - From Helke
Further to The Future of Complementary/Integrative Medicine & Patient Choice, here is an important must read and act note from Helke Ferrie, a superb Medical Science Writer and Publisher. Now that the true colours of the well known shortcomings of allopathic medicine are being discovered en mass, the screws are being tightened by the pharmaceutical masters on their medical puppets. It seems that they are prepared to stop at nothing.... [read more]
September 16, 2011 - Chris Gupta